THE ANATOMY OF “CHEMO BRAIN”

 A Neurological Exploration of Cancer Treatment–Related Cognitive Impairment

By: Lennard M. Goetze, Ed.D / Robert L. Bard, MD / Noelle Cutter, Ph.D 

Cancer treatment saves lives. Yet for many survivors, recovery includes an unexpected neurological aftermath—often described as “chemo brain.” Clinically referred to as cancer-related cognitive impairment (CRCI), this condition involves changes in memory, attention, processing speed, and executive function. For organizations like the Male Breast Cancer Global Alliance (MBCGA), understanding this phenomenon is critical—not only for survivorship care but for addressing its psychological and neurological implications.

---

FOREWORD: ABOUT CHEMO BRAIN IN MEN

When Cheri Ambrose, founder of the Male Breast Cancer Global Alliance, speaks about survivorship, she emphasizes that men with breast cancer face a uniquely isolating journey—especially when it comes to cognitive side effects like chemo brain. “Men are already navigating a diagnosis most people think only affects women,” she notes. “Then they’re expected to endure chemotherapy quietly, without complaint, including the mental fog that follows.”

Biologically, chemo brain does not discriminate by sex; the underlying mechanisms—neuroinflammation, oxidative stress, and white matter disruption—affect male and female brains similarly. However, men may experience the consequences differently. Many male patients are older at diagnosis, often still working, and may feel intense pressure to maintain performance and composure. Subtle memory lapses or slowed processing can therefore feel threatening to identity, livelihood, and independence.

There is also bias. Cognitive symptoms in women with breast cancer have been widely studied for decades. In contrast, male breast cancer patients are underrepresented in research, and their neurological complaints may be minimized or overlooked. Ambrose stresses that men deserve recognition, screening, and support. “Chemo brain isn’t weakness,” she says. “It’s survivorship—and men need space to talk about it.” 

What Is “Chemo Brain”?

Patients frequently describe chemo brain as mental fogginess. Words are harder to retrieve. Multitasking becomes overwhelming. Names, dates, or familiar routines may temporarily slip away. For some, these changes are mild and short-lived. For others, they persist for months—or even years.

 

Studies estimate that 15–25% of patients experience significant stress, anxiety, or depression during cancer treatment, and cognitive symptoms often amplify these emotional burdens. Cognitive decline and mental health changes frequently interact in a bidirectional way: stress worsens attention and memory, while cognitive struggles heighten anxiety.

But is it really caused by chemotherapy alone?

---

 

Is It Really from Chemotherapy?

The term “chemo brain” is somewhat misleading. Cognitive impairment may stem from:

·        Chemotherapy

·        Radiation (especially to the brain or chest region affecting vascular supply)

·        Hormonal therapies

·        Chronic inflammation

·        Immune activation

·        Emotional trauma and sleep disruption

Chemotherapy remains a primary contributor, but it is not the sole cause. The brain is influenced by systemic inflammation, vascular changes, oxidative stress, and hormonal fluctuations—all common in cancer treatment.

---

 

The Chemical Impact on the Brain

Certain chemotherapy agents are more strongly associated with cognitive effects. Two commonly cited drugs include:

·        Methotrexate – known to cross the blood-brain barrier and interfere with folate metabolism, essential for DNA repair and neuronal health.

·        Doxorubicin (often nicknamed the “Red Devil”) – linked to oxidative stress and inflammatory cytokine release.

These drugs do not simply “slow thinking.” Research suggests they may:

·        Trigger neuroinflammation

·        Disrupt white matter integrity (myelin damage)

·        Alter hippocampal function (critical for memory formation)

·        Increase oxidative stress within neurons

·        Reduce neurogenesis (new brain cell formation)

 

Myelin and White Matter Damage

Myelin acts as insulation for nerve fibers, ensuring rapid electrical signaling. Damage to myelin slows communication between brain regions. This can affect attention, working memory, and processing speed.

 

Hippocampal Vulnerability

The hippocampus, central to learning and memory consolidation, is particularly sensitive to inflammatory and oxidative stress. Some imaging studies show volume reduction or altered connectivity in this region following treatment.

 

Inflammation and Cytokines

Chemotherapy can elevate inflammatory markers such as TNF-alpha and IL-6. Chronic neuroinflammation interferes with neurotransmitter balance and synaptic plasticity, contributing to mental fog.

---

Motor Cortex and the Nervous System

While chemo brain is usually described in cognitive terms, the neurological network extends beyond memory centers.

 

The motor cortex—responsible for voluntary movement—can be indirectly affected when white matter pathways are compromised. Patients sometimes report:

·        Slower motor coordination

·        Reduced reaction time

·        Subtle fine motor changes

 

These symptoms reflect disrupted neural signaling rather than muscle damage. The brain’s communication highways—especially frontal-subcortical circuits—may operate less efficiently during or after treatment.

---

 

Permanent Damage?

For most patients, cognitive changes improve within months after treatment ends. However, in more severe cases—particularly with high-dose or intrathecal chemotherapy—long-lasting impairment can occur.

 

The most serious presentations may involve:

·        Persistent executive dysfunction

·        Severe short-term memory loss

·        Impaired concentration lasting years

·        Structural white matter changes visible on imaging

 

These cases are uncommon but documented. Risk factors include:

·        High cumulative chemotherapy doses

·        Preexisting vascular disease

·        Older age

·        Coexisting depression or anxiety

·        Sleep disorders

 

Importantly, not all cognitive symptoms represent irreversible damage. Neuroplasticity—the brain’s ability to reorganize and form new connections—remains active throughout life.

---

Mental Health and Cognitive Overlap

Cognitive impairment does not exist in isolation. Anxiety and depression affect 15–25% of cancer patients. Stress hormones like cortisol can further impair hippocampal function. Sleep disturbances—common during treatment—compound attention deficits.

 

Emotional trauma from a cancer diagnosis also activates survival-based neural circuits. Hypervigilance, rumination, and fatigue may mimic or amplify cognitive symptoms.

In other words, chemo brain is often a multi-layered neurological and psychological response—not merely a side effect of one drug.

---

 

What Can Be Done?

Treatment and Recovery Strategies

While chemo brain can be distressing, proactive management significantly improves outcomes. Treatment focuses on rehabilitation rather than cure, leveraging the brain’s adaptive capacity.

 

1. Cognitive Rehabilitation

Working with a neuropsychologist can help identify specific deficits and develop personalized compensatory strategies. Structured cognitive training improves attention span, task sequencing, and working memory.

 

2. Brain Exercises

Challenging the brain stimulates neural pathways. Activities such as learning a language, playing a musical instrument, solving logic puzzles, or engaging in memory games promote synaptic growth. Repetition strengthens alternative neural routes when primary ones are disrupted.

 

3. Physical Activity

Even light daily exercise improves cerebral blood flow and reduces inflammation. Five to twenty minutes of moderate movement can enhance executive function and mood. Aerobic activity supports hippocampal regeneration and boosts brain-derived neurotrophic factor (BDNF), a key growth protein.

 

4. Organizational Tools

External structure reduces cognitive strain. Practical supports include:

·        Daily planners

·        Digital reminders

·        Task lists

·        Pill organizers

·        Designated locations for frequently used items

Reducing multitasking and focusing on one task at a time improves performance.

 

5. Stress Reduction

Mindfulness, yoga, meditation, breathing exercises, and acupuncture help regulate stress hormones. Lower cortisol levels support hippocampal recovery and emotional balance.

 

6. Medication

In selected cases, physicians may prescribe stimulant medications such as methylphenidate to improve alertness and concentration. These are used cautiously and under supervision.

 

7. Sleep Optimization

Sleep is non-negotiable for memory consolidation. Addressing insomnia, sleep apnea, or circadian disruption can significantly improve cognitive clarity.

---

 

Daily Coping Tips

·        Avoid multitasking.

·        Write things down immediately.

·        Maintain consistent routines.

·        Ask for help when needed.

·        Communicate openly with your care team.

 

A Message for Survivors

Chemo brain is real—but it is not a personal failure. It reflects the biological intensity of cancer therapy interacting with emotional stress and systemic inflammation. For most survivors, improvement occurs gradually. For those with persistent symptoms, structured rehabilitation and lifestyle support can restore meaningful function. Understanding the anatomy of chemo brain empowers patients and advocates alike. It reminds us that survivorship includes brain health—and that cognitive recovery deserves the same attention as physical healing.

 

AFTERMATH

“Strength with Strategy: Navigating Cancer Treatment Without Letting Fear Decide”

By Dr. Robert L. Bard, MD, DABR, FAIUM, FASLMS

I have spent decades looking inside the human body—literally and figuratively. As a diagnostic radiologist, I see what disease does, but I also see what treatment does. And sometimes, the after-effects of treatment deserve just as much attention as the disease we are fighting.

Chemotherapy is powerful. It is designed to be. These agents are cytotoxic—they destroy rapidly dividing cells. That includes cancer cells, but it can also include healthy tissue. When we talk about “chemo brain,” neuropathy, fatigue, cardiac strain, or hormonal shifts, we are talking about the biological cost of a very aggressive intervention. This is not an argument against chemotherapy. It is an argument for awareness.

Most chemotherapy drugs went through rigorous clinical trials. They were studied, tested, refined. But trials are conducted under structured conditions, often with narrowly defined patient populations. Real life is broader. Patients have coexisting conditions. They have different genetic susceptibilities. They metabolize drugs differently. So while the data may show statistical safety and benefit, the individual experience can vary widely. This is why I emphasize being judicious.

A cancer diagnosis triggers fear. That is natural. The word alone can send the nervous system into overdrive. But decisions made in a state of panic are rarely optimal. I encourage patients to pause—not to delay necessary care recklessly, but to gather information thoughtfully.

Ask:
What is the stage?
What is the biological subtype?
What are the absolute benefits of this therapy in my case?
What are the short-term and long-term risks?
Are there alternative regimens?

 

MEDICINE IS NOT ONE-SIZE-FITS-ALL

It is increasingly personalized. We must also recognize that research evolves. New imaging tools, genomic profiling, and targeted therapies are changing the landscape. The “standard of care” today may not look like it did even five years ago. Staying informed matters.

And when you research, do not limit yourself to one information pipeline. Search engines filter content differently. I often advise patients to use platforms like DuckDuckGo in addition to Google. Different algorithms can yield different studies, perspectives, and international viewpoints. Knowledge should not be confined to one corporate lens.

That said, not all information online is credible. Prioritize peer-reviewed sources, academic institutions, and recognized medical organizations. Bring what you find back to your physician. A good doctor will not be threatened by your curiosity. They will welcome it.

MOST IMPORTANTLY: GET A SECOND OPINION

A second opinion is not an act of defiance. It is an act of responsibility. In radiology, we routinely double-read complex imaging. Why? Because perspective improves accuracy. Oncology decisions are no less significant. Another specialist may confirm the plan—or offer a modification that better suits your physiology or priorities.

I have seen patients rush into aggressive regimens only to later question whether all components were necessary. I have also seen patients avoid recommended therapy out of fear, to their detriment. The balance lies in informed, measured decision-making.

Cancer treatment is strong because cancer can be strong. But strength must be matched with precision. Our job as physicians is not only to attack disease but to preserve quality of life. Cognitive clarity, neurological health, cardiac resilience—these matter.

Do not let fear dictate your path. Let data, dialogue, and discernment guide you. Ask questions. Seek clarity. Expand your research. And always, always empower yourself with another professional perspective.

That is not hesitation. That is wisdom.

 

 

 

 

 

 

 

 

 

 

Male Breast Cancer and Dysfunction in Neurotransmitter Signaling

Male breast cancer (MBC), though less prevalent than female breast cancer, carries a distinct set of diagnostic, treatment, and survivorship challenges that extend beyond tumor control alone. Increasing clinical attention is being directed toward the neurological and neuromuscular consequences of cancer and cancer therapies, including chemotherapy-induced peripheral neuropathy, treatment-related deconditioning, chronic pain syndromes, fatigue, and loss of functional mobility. These complications reflect not only structural nerve injury, but disruptions in neurotransmitter signaling, microvascular integrity, inflammatory balance, and neuromuscular recruitment patterns.

Neurotransmitters govern the chemical language of nerve-to-muscle and nerve-to-organ communication, shaping sensation, movement, pain perception, autonomic regulation, and recovery capacity. In oncology populations, neurotoxic therapies, metabolic stress, and inflammatory burden can impair these signaling pathways, contributing to numbness, weakness, gait instability, and reduced quality of life. For male breast cancer patients—who already face diagnostic delays and care disparities—neuropathy and neuromuscular dysfunction may remain under-recognized and under-monitored.

This article examines the role of neurotransmitter signaling in neuropathy, the neurovascular mechanisms underlying treatment-related nerve injury, and the emerging role of non-invasive neuromuscular activation strategies within an imaging-guided, evidence-based model of supportive care for men navigating breast cancer diagnosis, treatment, and recovery.

How Chemical Signaling Shapes Pain, Movement, and Recovery
By: Lennard M. Goetze, Ed.D  | Polina Dembe-Petaludis, Ph.D  | Edited by: Daniel Root

Neurotransmitters are the chemical messengers of the nervous system, responsible for transmitting signals between neurons, muscles, glands, and organs. Every movement, sensation, thought, and autonomic function depends on their precise release, reception, and clearance. Disruption in neurotransmitter signaling contributes to neurological disorders, chronic pain syndromes, neuropathy, muscular atrophy, fatigue syndromes, and impaired neuromuscular coordination.

In clinical and rehabilitation medicine, growing attention has been placed on technologies that interface with the nervous system—such as Electrical Muscle Stimulation (EMS)—to support neuromuscular recruitment, circulation, pain modulation, and functional recovery. Understanding how neurotransmitters operate at the synaptic and neuromuscular junction level provides a scientific foundation for evaluating how such technologies may assist recovery, movement retraining, and symptom management in patients with neuropathy, cancer treatment–related nerve damage, metabolic disorders, and inflammatory conditions.

This review examines what neurotransmitters are, how they relate to neuropathy, how they affect the body, whether they “die” or become dormant, and how neuromuscular technologies such as EMS interact with neurotransmitter signaling to restore functional activity.

Do Neurotransmitters Die or Become Dormant?

Neurotransmitters themselves do not “die.” They are synthesized, released, recycled, and degraded in continuous cycles. What can deteriorate is:

·        The neuron producing the neurotransmitter

·        The synapse’s structural integrity

·        The receptor’s responsiveness

·        The metabolic environment needed to sustain neurotransmitter production

In neuropathy and neurodegenerative conditions, signaling pathways may become functionally “dormant” due to reduced neural firing, impaired circulation, mitochondrial dysfunction, oxidative stress, or inflammatory injury. This creates a state where nerves and muscles exist anatomically but are under-stimulated and under-recruited.

This dormant-like state is reversible in some cases, particularly when neural pathways remain intact but inactive. Rehabilitation strategies aim to re-engage these pathways through mechanical loading, sensory input, neuromuscular activation, circulation enhancement, and metabolic support.

Conclusion

Neurotransmitters represent the biochemical language of movement, sensation, and repair. In neuropathy and chronic disease states, neurotransmitter signaling is disrupted not because the system “dies,” but because metabolic, vascular, and inflammatory conditions impair neural function. Technologies such as Electrical Muscle Stimulation operate within this biological framework by activating neuromuscular circuits, preserving synaptic signaling, and supporting rehabilitation in patients with partial neural compromise.

When integrated into a clinically guided, evidence-based model—including imaging validation, metabolic support, circulation enhancement, and movement retraining—neuromuscular stimulation technologies serve as functional tools for preserving performance, restoring activity, and supporting recovery. The future of neurorehabilitation lies not in isolated devices, but in image-guided, physiologically grounded protocols that respect the complex chemical–electrical language of the nervous system.

References:

1) Pieber, K., Herceg, M., & Paternostro-Sluga, T. (2010). Electrotherapy for the treatment of painful diabetic peripheral neuropathy: A review. Journal of Rehabilitation Medicine, 42(4), 289–295. doi:10.2340/16501977-0554. (2) Weintraub, M. I., Herrmann, D. N., Smith, A. G., Backonja, M. M., & Cole, S. P. (2009). Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 90(7), 1102–1109.

2) Transcutaneous electrical nerve stimulation. (2026). In Encyclopedia of Physical Therapy. Retrieved from https://en.wikipedia.org/wiki/Transcutaneous_electrical_nerve_stimulation

3) Pulsed electromagnetic field therapy. (n.d.). In Wikipedia. Retrieved from https://en.wikipedia.org/wiki/Pulsed_electromagnetic_field_therapy

4) Peripheral neuropathy. (n.d.). In Wikipedia. Retrieved from https://en.wikipedia.org/wiki/Peripheral_neuropathy

5) Battecha, K., et al. (2017). Efficacy of pulsed electromagnetic field on diabetic peripheral neuropathy. Bulletin of Faculty of Physical Therapy, 22, 9–14.

6) Graak, V., Chaudhary, S., Sandhu, B. S., & others. (2009). Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy. PMCID: PMC2812751.

7) Cochrane Database (2017). Transcutaneous electrical nerve stimulation for neuropathic pain. (This is a systematic review you can cite.)

Disclaimer:
This article is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. The content reflects current scientific understanding and clinical perspectives but is not a substitute for professional medical evaluation or individualized care. Readers should consult qualified healthcare providers regarding any medical condition, diagnosis, or treatment decisions.

Immunolytics Review

 Inside Immunolytics’ Diagnostic Framework

By: Lennard M. Goetze, Ed.D

Mold exposure is increasingly recognized as one of the most pervasive and misunderstood environmental health risks affecting modern buildings. While often framed as a household maintenance issue, mold contamination carries wide-ranging implications for respiratory health, immune regulation, neurological function, and chronic disease susceptibility. At the center of translating mold science into accessible diagnostic tools is Immunolytics, a laboratory founded to bridge environmental assessment with actionable health insight. Guided by J.W. Biava, a chemical engineer with decades of laboratory experience and advanced training in environmental exposures, Immunolytics has positioned itself as a practical yet scientifically grounded authority in mold analysis.

.

Engineering Roots and Environmental Focus

Biava’s background distinguishes Immunolytics from many mold testing services. Trained formally as a chemical engineer with an environmental emphasis, Biava entered laboratory science at an unusually early age, working within analytical labs long before specializing in mold. His career path evolved organically from water microbiology and environmental testing into mold analysis as building designs and indoor air quality challenges changed over time.

According to Biava, modern construction methods—particularly the widespread use of cellulose-based materials—have created what he refers to as “mold candy,” providing ideal growth substrates whenever moisture intrusion occurs. This reality has shifted mold from a regional nuisance to a national health concern, affecting homes, schools, hospitals, and workplaces across diverse climates

 

.

PRACTICAL MOLD TESTING FOR REAL-WORLD ENVIRONMENTS

Immunolytics’ approach emphasizes usability without sacrificing scientific rigor. The company provides do-it-yourself mold testing kits designed to capture meaningful exposure data while remaining accessible to homeowners, clinicians, inspectors, and facility managers. Two primary sampling methods form the foundation of Immunolytics’ testing model:

• Gravity air plates, which measure airborne mold exposure by allowing spores to settle naturally onto nutrient media
• Surface swabs, used to sample visible or suspected contamination from walls, HVAC components, furniture, or water-damaged materials

 

Biava explains that gravity plates are particularly effective for assessing actual breathing exposure, rather than theoretical spore presence. “We’re trying to understand what people are truly inhaling day to day,” he notes, emphasizing that meaningful exposure assessment must reflect lived environments rather than isolated measurements.

 

Laboratory Analysis: Genus Identification and Colony Quantification

Once samples arrive at Immunolytics’ laboratory, analysis extends beyond simple detection. Each sample is evaluated for mold genus identification and colony counts, two metrics critical for distinguishing background environmental mold from amplified contamination.

Different mold genera exhibit distinct growth behaviors and health implications. Lower water-activity molds such as Aspergillus and Penicillium may signal chronic moisture imbalance, while higher water-activity organisms such as Chaetomium or Stachybotrys often indicate prolonged water damage. Colony counts further contextualize findings, helping determine whether mold presence reflects incidental exposure or an active environmental problem. Biava stresses that mold rarely exists as a single organism. “It’s the pattern that matters—the types present, their abundance, and where they’re growing,” he explains, highlighting the importance of ecological interpretation rather than isolated results.

.

Reporting Designed to Educate and Guide

Immunolytics’ reports are structured not merely as laboratory summaries but as educational tools. Each report includes:

• Photographic documentation of cultured samples
• Identified mold genera and colony counts
• Contextual explanations of potential health implications
• Guidance on remediation priorities and next steps

This emphasis on clarity reflects Biava’s belief that data without interpretation leaves clients uncertain and vulnerable. Mold testing, he argues, should empower informed decision-making rather than generate fear or confusion.

 

Expert Consultation as a Core Service

One of Immunolytics’ most distinctive features is its included expert consultation model. Every client—regardless of the number of samples submitted—receives a free phone consultation with an Indoor Environmental Professional (IEP). During these sessions, results are reviewed in context, questions are addressed, and practical recommendations are provided.

Biava views this consultative layer as essential. “Mold testing without interpretation is incomplete,” he notes. “People need help understanding what the results mean and what actions actually improve health.” Following consultations, clients receive additional educational materials addressing remediation strategies, air quality improvement, and exposure reduction. 

.

Health Risks: Why Mold Demands Urgent Attention

Central to Biava’s work is correcting misconceptions about mold-related illness. Mold exposure, he explains, affects human health through multiple biological mechanisms:

1. Allergenic responses, such as sneezing, coughing, and asthma exacerbation
2. Infectious potential, including rare but serious invasive mold diseases
3. Mycotoxin production, with toxins capable of disrupting neurological, endocrine, and immune function
4. Antigen and superantigen effects, where mold proteins trigger immune-mediated inflammation independent of toxins

Biava cautions against dismissing “common” molds as harmless. Even ubiquitous genera such as Cladosporium may provoke significant immune responses in susceptible individuals. He also highlights the limitations of current mycotoxin testing, noting that clinical panels typically screen for only a fraction of the thousands of known mycotoxins associated with molds.

From Detection to Prevention

Beyond diagnostics, Immunolytics collaborates on natural and botanical solutions for mold-affected environments, alongside broader indoor wellness initiatives. Biava’s philosophy aligns with a foundational principle of toxicology: either remove the toxin from the person or remove the person from the toxin. Effective mold remediation, he argues, must prioritize environmental correction before medical intervention.

This preventative emphasis positions mold testing not as an endpoint, but as the first step in restoring healthy indoor ecosystems.

 

Conclusion: Immunolytics represents a pragmatic yet scientifically grounded response to a growing public health challenge. Through accessible testing kits, detailed laboratory analysis, comprehensive reporting, and expert consultation, the company offers a model for environmental diagnostics that prioritizes clarity, prevention, and health outcomes. Guided by J.W. Biava’s engineering discipline and environmental expertise, Immunolytics underscores an urgent truth: mold exposure is not a marginal issue. It is a widespread, biologically complex hazard demanding informed detection, timely remediation, and sustained public awareness.

 

Upcoming Webinar- 5/19/2026- with Dr. Sarah Persing

Reconstructing Confidence: Dr. Sarah Persing on Breast Reconstruction for Men with Breast Cancer

Male breast cancer remains widely misunderstood and under-discussed, leaving many patients without clear guidance on what comes after treatment. While survival outcomes have improved with earlier detection and better therapies, the physical and emotional aftermath of surgery can be profound—particularly for men who undergo mastectomy and experience visible changes to the chest. On March 19 at 11:00am EST, the Male Breast Cancer Global Alliance (MBCGA) will host a Spring Webinar featuring Dr. Sarah Persing, a plastic and oncoplastic breast surgeon and Associate Professor of Surgery at Tufts University School of Medicine, to address one of the most overlooked aspects of male breast cancer care: breast reconstruction.

Why Reconstruction Matters for Men

For many men, breast reconstruction is not initially presented as part of the treatment conversation. Reconstruction is often perceived as a “women’s issue,” despite the reality that men can experience significant chest wall deformity, scarring, asymmetry, and functional concerns after breast cancer surgery. These physical changes can impact posture, comfort in clothing, and body image—factors that carry psychological weight during recovery and survivorship.

Modern reconstructive approaches recognize that restoration is not cosmetic vanity; it is part of comprehensive healing. Reconstruction can help restore chest contour, address tissue deficits, improve symmetry, and, in select cases, incorporate techniques that preserve or reconstruct the nipple-areolar complex when oncologically appropriate. For male patients, even subtle contouring can significantly influence confidence and the willingness to re-engage socially and physically after treatment.

Dr. Persing’s Expertise in Oncoplastic Reconstruction

Dr. Persing brings a rare blend of expertise in plastic surgery, microsurgery, and oncoplastic breast surgery, with a clinical focus on breast cancer and reconstructive techniques. Her work bridges cancer control with aesthetic and functional restoration—an approach that reframes reconstruction as an integrated part of cancer surgery rather than an afterthought.

In the upcoming webinar, Dr. Persing is expected to discuss how reconstructive planning can begin at the time of cancer surgery, not months later. This “oncoplastic” model coordinates tumor removal with reconstructive strategy to optimize outcomes while maintaining oncologic safety. For men, this may include careful management of skin flaps, contour refinement of the chest wall, and microsurgical options in more complex cases where tissue deficits are significant.

Current Approaches to Breast Reconstruction for Men

Reconstruction for men differs from traditional breast reconstruction in women. Rather than restoring breast volume, the goal is to re-establish a natural male chest contour. Options may include:

·        Local tissue rearrangement to smooth contour irregularities

·        Fat grafting to correct depressions or asymmetry

·        Scar revision and chest wall contouring

·        Nipple-areolar reconstruction or preservation when oncologically appropriate

·        Microsurgical techniques in cases involving extensive tissue loss or prior radiation

Radiation therapy and lymph node surgery can complicate healing, making individualized planning essential. Dr. Persing’s experience in microsurgery and oncoplastic techniques positions her to address these challenges while minimizing functional limitations and long-term discomfort.

A Patient-Centered Conversation

Beyond surgical technique, the webinar will emphasize the importance of shared decision-making. Men are often not informed that reconstruction is an option, and many do not realize that even modest reconstructive interventions can improve comfort, posture, and self-image. Education empowers patients to ask better questions, set realistic expectations, and advocate for comprehensive survivorship care.

Dr. Persing’s presentation is designed to equip patients, caregivers, and clinicians with practical knowledge: when to consider reconstruction, what questions to ask a surgical team, how timing interacts with chemotherapy or radiation, and what recovery realistically looks like.

Why This Webinar Matters

As male breast cancer awareness grows, so must the sophistication of post-treatment care. Reconstruction is not about aesthetics alone—it is about restoring wholeness after a life-altering diagnosis. The March 19 webinar offers an opportunity to bring clarity to an often-overlooked topic and to normalize reconstruction as part of standard care for men with breast cancer.

By spotlighting reconstructive options through the lens of an experienced oncoplastic surgeon, MBCGA continues its mission to close care gaps, challenge outdated assumptions, and elevate survivorship standards for men worldwide.

PART 2:

Beyond Survival: Why Education on Breast Reconstruction for Men Matters Now More Than Ever

By Cheri Ambrose, Founder & CEO, Male Breast Cancer Global Alliance (MBCGA)

Every time we host an educational forum, I am reminded why the work of the Male Breast Cancer Global Alliance exists. But some conversations land differently. Dr. Sarah Persing’s presentation on breast reconstruction for men was one of those moments—where science, dignity, and long-overdue inclusion intersected in a way that felt both affirming and urgent.

For too long, men with breast cancer have been excluded from conversations about reconstruction. Not intentionally, perhaps—but systemically. The language, the protocols, even the assumptions around post-surgical care have been built on a model that does not fully recognize male patients as needing the same comprehensive, whole-person recovery pathway. Dr. Persing’s presentation made something very clear: reconstruction is not cosmetic—it is restorative. It is about helping people feel whole again after cancer takes something away.

Education on this topic is tantamount in today’s cancer world because survivorship has evolved. We are no longer only measuring success by survival statistics. We are measuring it by quality of life, by how people return to their lives, relationships, work, and sense of self. Chest wall deformity, scarring, asymmetry, and physical discomfort may seem “minor” on a medical chart, but to a survivor, these are daily reminders of trauma. When we normalize reconstruction as part of the continuum of care for men, we validate their experience and restore agency to their healing journey.

What struck me most was how far reconstructive procedures have evolved. We are no longer in an era of one-size-fits-all surgery. Today’s oncoplastic and microsurgical approaches integrate cancer control with restoration of form and function. Techniques like contour refinement, fat grafting, scar revision, and chest wall reconstruction reflect decades of innovation—born from listening to patients and responding with better science. This evolution mirrors what we have seen in male breast cancer treatment itself: improved diagnostics, more tailored therapies, more nuanced understanding of male-specific disease patterns, and growing awareness among clinicians.

As an advocate and as someone who has witnessed countless men navigate breast cancer in silence, I see education as the bridge between medical progress and real-world impact. Knowledge dismantles stigma. It opens doors for conversations that men may be afraid to start. It equips caregivers to support more effectively. And it gives clinicians permission to broaden their standard of care beyond tumor removal to true restoration.

The aftermath of this presentation is not just information—it is momentum. Momentum toward inclusive care models. Momentum toward better-informed patients. Momentum toward a cancer care culture that recognizes men as deserving of the same post-treatment options, compassion, and dignity historically afforded to women.

At MBCGA, our mission has always been to close gaps in awareness, research, and care. This conversation about breast reconstruction for men is one of those gaps finally being filled. The more we educate, the more we normalize these options, and the more we invite men into these conversations early in their care, the closer we move toward a future where no patient is overlooked simply because of gender.

This is what progress looks like: not just treating cancer—but treating the whole person who survives it.